Millie
your market intelligence analyst
Search Results
349 results
Your search is now limited to «Ovarian Cancer» expert search.
Ovarian Cancer News Today 11/15/2019 12:50
The study, " Assisted reproductive technology treatment and risk of ovarian cancer—a nationwide population-based cohort study ," was published in the journal Human Reproduction.
More from Ovarian Cancer News Today:
BioNewsFeeds 11/15/2019 12:50
Polycystic ovarian syndrome and other causes of female infertility were not associated with a significant increase in ovarian cancer risk following use of ART.
More from BioNewsFeeds:
ESMO News (EU) 11/15/2019 03:23
In randomised, phase III GOG-0213 study that involved patients with platinum-sensitive, recurrent epithelial ovarian cancer, secondary surgical cytoreduction followed by chemotherapy did not result in longer overall survival (OS) than chemotherapy alone.
More from ESMO News (EU):
Patients with platinum-resistant recurrent epithelial ovarian cancer initiating apatinib treatment from January 2016 to December 2018 were included.
More from International Journal of COPD:
ClinicalTrials.gov 11/14/2019 11:09
Condition : Ovarian Cancer Intervention : Drug: W_ova1 Vaccine Sponsors : University Medical Center Groningen; Biontech RNA Pharmaceuticals GmbH Not yet recruiting.
More from ClinicalTrials.gov:
PubMed News (NIH) 11/13/2019 23:00
Status Public on Nov 14, 2019 Title FXYD5 (dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer Organism Homo sapiens Experiment type Expression profiling by array Summary High-grade serous ovarian carcinoma (HGSOC) is generally associated with a very dismal prognosis.
More from PubMed News (NIH):
News-Medical.net 11/13/2019 22:14
Unlike most cancerous tumors, which grow on the surface of the ovary and then spread into the abdomen, Garcia's cancer apparently lived inside her ovary and grew there.
More from News-Medical.net:
Channel NewsAsia (Singapore) 11/13/2019 17:30
The volunteers had recurrent epithelial ovarian, primary peritoneal, or Fallopian-tube cancer.
More from Channel NewsAsia (Singapore):
Business Wire 11/13/2019 04:00
The reimbursement of Rubraca in Italy is an important step in the ovarian cancer treatment pathway, as it has shown to be effective across a broad population of women with relapsed ovarian cancer,” said Patrick J. Mahaffy, President and CEO of Clovis Oncology.
More from Business Wire:
Thousands of women's lives 'could be at risk from ovarian cancer'.
More from Mail on Sunday (United Kingdom):
Healio News 11/08/2019 10:57
Part of this is due to the success we’ve had recently in ovarian cancer.
More from Healio News:
The high-probability conclusion is that bevacizumab-based targeting of vascular endothelial growth factor (VEGF) in ovarian cancer fails to increase median lifespan.
More from American Society of Clinical Oncolgy (ASCO):
GlobeNewswire 11/05/2019 08:00
The OVATION 2 Study will enroll up to 130 patients with Stage III/IV ovarian cancer, with 12 to 15 patients in the Phase I portion and up to 118 patients in the Phase II portion.
More from GlobeNewswire:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications